$21.75 0.13 (+0.60%)
11/6/2009 4:00 PM

QIAGEN N.V. (QGEN)

CAPS Rating: 3 out of 5

The Company is a provider of innovative technologies and products for preanalytical sample preparation and linked molecular assay solutions.

Current Price $21.75 Mkt Cap $4.33B
Open $21.30 P/E Ratio 25.14
Prev. Close $21.62 Div. (Yield) N/A (N/A)
Daily Range $21.26 - $21.75 Volume 741,925
52-Wk Range $13.82 - $23.35 Avg. Daily Vol. 1,243,000

QGEN News and Commentary

Caps

How do you think QGEN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

93 Outperform
5 Underperform
 

All-Star Members

35 Outperform
4 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top QGEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

SaltyGenes (67.01)
Submitted December 23, 2007

genetic research will be as all consuming to our children's generation as communications have been to ours. humans are almost as compelled to look into themselves and communicate as they are to eat and mate. cisco anyone?

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

QGEN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about QGEN.

Recs

0
Member Avatar AHavoc (< 20) Submitted: 7/2/2008 10:40:40 PM : Outperform Start Price: $20.70 QGEN Score: +18.11

Recent introduction of new tools; recent company acquisitions; eps good, relative price strength good; volume and price now pulling above 50 day moving average, looks to grow.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar healthcareinvest (59.85) Submitted: 5/5/2008 1:42:30 PM : Outperform Start Price: $22.25 QGEN Score: +18.79

A sample and assay technology company with more than 500 consumable products and automated solutions-Netherlands based. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

Products are sold to a diverse customer base, including academic research centers, pharmaceutical and biotechnology companies, molecular diagnostics laboratories as well as to customers in applied testing markets such as forensics, animal or food testing, and pharmaceutical process control.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar cayamax (< 20) Submitted: 1/17/2008 1:29:25 PM : Outperform Start Price: $21.65 QGEN Score: +17.96

Biomed/Biotech should be one of the good segments in this economy.

Report this Post 0 Comments | Reply | Permalink
View All 11 Pitches »

Leaderboard

Find the members with the highest scoring picks in QGEN.

Score Leader

mjharding4

mjharding4 (89.14) Score: +66.46

The Score Leader is the member with the highest score across all their picks in QGEN.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
mjharding4 89.14 8/24/2006 Outperform 1Y $14.10 +54.26% -12.21% +66.46
dingoenos 89.46 8/25/2006 Outperform 3M $14.18 +53.39% -11.86% +65.25
DGrimes75 88.62 8/25/2006 Outperform 1Y $14.18 +53.39% -11.86% +65.25
jackvaron 88.03 12/22/2006 Outperform 1Y $15.15 +43.56% -19.43% +62.99
jafcb 57.47 1/11/2007 Outperform 3W $15.59 +39.51% -20.47% +59.98
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. indyjoneses 99.41 1/9/2007 Outperform 3Y $15.50 +40.32% -19.53% +59.85 1 Comment
MesaWeb < 20 1/9/2007 Outperform 5Y $15.61 +39.33% -19.49% +58.82 1 Comment
HippeO < 20 9/29/2006 Outperform 1Y $15.74 +38.18% -15.11% +53.30
damastafunk < 20 8/21/2007 Outperform NS $16.63 +30.79% -22.33% +53.12
MajorNutcase 91.01 1/16/2007 Outperform 5Y $16.46 +32.14% -20.52% +52.66
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackBarclaysCap 86.02 10/8/2009 Outperform NS $20.90 +4.07% +1.77% +2.30
TrackWedbush < 20 3/11/2009 Outperform NS $16.12 +34.93% +49.34% -14.42
TrackJefferies 75.83 3/3/2009 Outperform NS $16.07 +35.35% +52.36% -17.01
TrackPiperJaff 80.38 10/11/2007 Outperform NS $21.16 +2.79% -28.53% +31.32
TrackDeutscheSec 89.50 3/22/2007 Outperform NS $17.05 +27.57% -21.06% +48.63

Featured Broker Partners